Profiling metastatic lesions from a pembro-refractory patient to reveal distinct genomic instabilities and non-uniform response to drug combinations, ex vivo

Chukwuemeka Ikpeazu; Munisha Smalley; Baraneedharan Ulaganathan; Allen Thayakumar; Shanthappa Basavaraja; Hans Gertje; Mark Lawson; Aaron Goldman

doi:10.1200/JCO.2018.36.15_suppl.e18021

$Profiling metastatic lesions from a pembro-refractory patient to reveal distinct genomic instabilities and non-uniform response to drug combinations, ex vivo$

Journal article

Peer reviewed

Profiling metastatic lesions from a pembro-refractory patient to reveal distinct genomic instabilities and non-uniform response to drug combinations, ex vivo

Chukwuemeka Ikpeazu, Munisha Smalley, Baraneedharan Ulaganathan, Allen Thayakumar, Shanthappa Basavaraja, Hans Gertje, Mark Lawson and Aaron Goldman

Journal of clinical oncology, Vol.36(15_suppl), pp.e18021-e18021

2018-05-20

DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.e18021

Metrics

10 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Profiling metastatic lesions from a pembro-refractory patient to reveal distinct genomic instabilities and non-uniform response to drug combinations, ex vivo
Creators: Chukwuemeka Ikpeazu - Sylvester Comprehensive Cancer Center
Munisha Smalley - Mitra Biotech
Baraneedharan Ulaganathan - Mitra Biotech
Allen Thayakumar - Mitra Biotech
Shanthappa Basavaraja - Mitra Biotech
Hans Gertje - Mitra Biotech
Mark Lawson - Mitra Biotech
Aaron Goldman - Mitra Biotech
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.e18021-e18021
Academic Unit: UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031740182202976